PT Trimegah Bangun Persada Tbk
IDX:NCKL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
560
1 360
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
PT Trimegah Bangun Persada Tbk
|
Revenue
|
29T
IDR
|
|
Cost of Revenue
|
-19.8T
IDR
|
|
Gross Profit
|
9.2T
IDR
|
|
Operating Expenses
|
-1.4T
IDR
|
|
Operating Income
|
7.7T
IDR
|
|
Other Expenses
|
266.2B
IDR
|
|
Net Income
|
8T
IDR
|
Income Statement
PT Trimegah Bangun Persada Tbk
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Interest Expense |
0
|
450 413
|
637 543
|
784 832
|
996 133
|
825 415
|
797 397
|
760 692
|
0
|
0
|
|
| Revenue |
17 600 443
N/A
|
17 299 778
-2%
|
23 857 861
+38%
|
25 105 648
+5%
|
26 419 267
+5%
|
26 936 488
+2%
|
26 965 262
+0%
|
28 058 849
+4%
|
28 256 508
+1%
|
28 989 437
+3%
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
(10 341 657)
|
(11 165 735)
|
(15 582 014)
|
(16 778 851)
|
(17 820 062)
|
(18 132 043)
|
(18 517 976)
|
(19 127 868)
|
(18 891 189)
|
(19 830 243)
|
|
| Gross Profit |
7 258 786
N/A
|
6 134 043
-15%
|
8 275 847
+35%
|
8 326 797
+1%
|
8 599 206
+3%
|
8 804 445
+2%
|
8 447 286
-4%
|
8 930 981
+6%
|
9 365 319
+5%
|
9 159 194
-2%
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(1 247 995)
|
(999 494)
|
(1 386 418)
|
(1 387 029)
|
(1 336 175)
|
(1 247 314)
|
(1 398 388)
|
(1 358 952)
|
(1 341 685)
|
(1 438 096)
|
|
| Selling, General & Administrative |
(1 330 157)
|
(1 002 395)
|
(1 374 072)
|
(1 345 907)
|
(1 323 966)
|
(1 337 941)
|
(1 497 108)
|
(1 455 682)
|
(1 389 586)
|
(1 391 457)
|
|
| Depreciation & Amortization |
(45 107)
|
(50 621)
|
(72 013)
|
(79 343)
|
(87 531)
|
(91 657)
|
(92 768)
|
(94 792)
|
(96 004)
|
(91 803)
|
|
| Other Operating Expenses |
127 269
|
53 522
|
59 667
|
38 221
|
75 321
|
182 284
|
191 488
|
191 522
|
143 905
|
45 164
|
|
| Operating Income |
6 010 792
N/A
|
5 134 548
-15%
|
6 889 429
+34%
|
6 939 768
+1%
|
7 263 031
+5%
|
7 557 132
+4%
|
7 048 898
-7%
|
7 572 029
+7%
|
8 023 634
+6%
|
7 721 098
-4%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
3 499 311
|
1 468 019
|
1 331 935
|
978 393
|
962 070
|
940 542
|
1 710 265
|
2 160 729
|
2 449 777
|
3 059 193
|
|
| Non-Reccuring Items |
31 821
|
(2 697)
|
(4 180)
|
(7 265)
|
(5 014)
|
(2 142)
|
(2 795)
|
(1 912)
|
(2 846)
|
(2 797)
|
|
| Total Other Income |
(254 915)
|
(68 269)
|
(41 811)
|
(57 343)
|
149 497
|
(53 941)
|
(85 549)
|
(65 715)
|
(56 884)
|
(13 110)
|
|
| Pre-Tax Income |
9 287 008
N/A
|
6 531 602
-30%
|
8 175 373
+25%
|
7 853 554
-4%
|
8 369 583
+7%
|
8 441 590
+1%
|
8 670 819
+3%
|
9 665 131
+11%
|
10 413 681
+8%
|
10 764 384
+3%
|
|
| Net Income | |||||||||||
| Tax Provision |
(1 297 515)
|
(865 580)
|
(1 107 319)
|
(993 353)
|
(966 890)
|
(1 033 978)
|
(958 451)
|
(969 215)
|
(988 554)
|
(1 054 262)
|
|
| Income from Continuing Operations |
7 989 492
|
5 666 021
|
7 068 054
|
6 860 201
|
7 402 693
|
7 407 613
|
7 712 368
|
8 695 916
|
9 425 127
|
9 710 122
|
|
| Income to Minority Interest |
(390 666)
|
(1 201 361)
|
(1 449 057)
|
(1 608 274)
|
(1 722 716)
|
(1 414 337)
|
(1 332 864)
|
(1 660 786)
|
(1 749 709)
|
(1 722 833)
|
|
| Net Income (Common) |
6 350 490
N/A
|
4 464 660
-30%
|
5 618 997
+26%
|
5 251 927
-7%
|
5 679 976
+8%
|
5 993 276
+6%
|
6 379 504
+6%
|
7 035 130
+10%
|
7 675 418
+9%
|
7 987 289
+4%
|
|
| EPS (Diluted) |
102.23
N/A
|
70.93
-31%
|
92.39
+30%
|
86.35
-7%
|
86.87
+1%
|
94.98
+9%
|
101.1
+6%
|
111.52
+10%
|
121.73
+9%
|
126.76
+4%
|
|